CJ CheilJedang Forms Partnership with T&R Biofab for Future Food Ventures

T&R Biofab with 3D Bioprinting Technology Advances into Alternative Meat Development

CJ CheilJedang is embarking on securing sustainable future food resources by integrating advanced innovative technologies.

On the 4th, CJ CheilJedang announced that it has signed a Joint Development Agreement (JDA) with T&R Biofab to co-develop alternative meat using 3D bioprinting technology. T&R Biofab is a meditech company with world-class technology in the field of regenerative medicine based on 3D bioprinting, developing artificial tissues using this technology.

Through the partnership between the two companies leading the food industry and the 3D printing medical field, they plan to elevate the level of alternative meat development and accelerate innovation for future food growth. Through this collaboration, they aim to develop alternative meat that surpasses the limitations of existing plant-based foods in terms of taste, texture, appearance, and nutrition.

According to market research firm Bloomberg Intelligence, the plant-based food market is expected to expand from $24.9 billion in 2020 to $162 billion by 2030. While plant-based foods have become a trend valued not only for animal welfare but also for health, nutrition, and eco-friendliness, replicating the texture and nutrition of animal-based foods remains a challenge.

Florian Biton, Head of Food Strategy Innovation at CJ CheilJedang, said, “Groundbreaking innovation occurs through convergence between different industries with expertise in diverse fields.” He added, “The partnership with T&R Biofab is a great opportunity to secure competitiveness in the plant-based food market. Through this, we expect to accelerate CJ CheilJedang’s innovation and establish new growth engines to succeed in the global market.”

This content was produced with the assistance of AI translation services.